Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Mamić, Matija ; Lucijanić, Marko ; Lorencin, Mia ; Suton, Petar ; Lukšić, Ivica
Impact of lymph node ratio on survival and recurrence outcomes in oral squamous cell carcinoma // International journal of oral and maxillofacial surgery, 51 (2022), 10; 1257-1263. doi: 10.1016/j.ijom.2022.01.009
Mamić, Matija ; Lucijanić, Marko ; Manojlović, Luka ; Müller, Danko ; Suton, Petar ; Lukšić, Ivica
Prognostic significance of extranodal extension in oral cavity squamous cell carcinoma with occult neck metastases // International journal of oral and maxillofacial surgery, 50 (2021), 3; 309-315. doi: 10.1016/j.ijom.2020.07.006
Suton, Petar ; Skelin, Marko ; Lukšić, Ivica
De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research // European archives of oto-rhino-laryngology, 278 (2021), 4599-4603. doi: 10.1007/s00405-021-06686-9
Suton, Petar ; Skelin, Marko ; Rakušić, Zoran ; Dokuzović, Stjepan ; Lukšić, Ivica
In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De- ESCALaTE // European archives of oto-rhino-laryngology, 276 (2019), 7; 2113-2114. doi: 10.1007/s00405-019-05485-7
Suton, Petar ; Bolanča, Ante ; Grgurević, Lovorka ; Erjavec, Igor ; Nikles, Iva ; Muller, Danko ; Manojlović, Spomenka ; Vukičević, Slobodan ; Petrovečki, Mladen ; Dokuzović, Stjepan et al.
Prognostic significance of bone morphogenetic protein 6 (BMP6) expression, clinical and pathological factors in clinically node-negative oral squamous cell carcinoma (OSCC) // Journal of cranio-maxillo-facial surgery, 47 (2019), 1; 80-86. doi: 10.1016/j.jcms.2018.10.003
Lukšić, Ivica ; Mamić, Matija ; Suton, Petar
Management of accessory parotid gland tumours: 32- year experience from a single institution and review of the literature // International journal of oral and maxillofacial surgery, 48 (2019), 9; 1145-1152. doi: 10.1016/j.ijom.2019.02.014
Suton, P. ; Skelin, M. ; Luksic, I.
Radiotherapy plus cisplatin (CDDP) or cetuximab (C225) in human papilloma-virus (HPV)- associated oropharyngeal cancer (OPC)? A dilemma finally resolved. An updated meta- analysis // Annals of oncology, 30 (2019), 5; v457-v457. doi: 10.1093/annonc/mdz252.017
Suton, Petar ; Skelin, Marko ; Rakušić, Zoran ; Dokuzović, Stjepan ; Lukšić, Ivica
Cisplatin-based chemoradiotherapy vs. cetuximab- based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE // European archives of oto-rhino-laryngology, 276 (2019), 5; 1275-1281. doi: 10.1007/s00405-019-05387-8
Mamić, Matija ; Manojlović, Luka ; Suton, Petar ; Lukšić, Ivica
Microcystic adnexal carcinoma-diagnostic criteria and therapeutic methods: case report and review of the literature // International journal of oral and maxillofacial surgery, 47 (2018), 10; 1258-1262. doi: 10.1016/j.ijom.2018.03.001
Petar Suton ; Marin Prpic ; Marko Tarle ; Matija Mamic ; Iva Nikles ; Ivica Luksic ;
Outcomes for patients with second primary malignancy after primary surgical treatment for early‐stage squamous cell carcinoma of the oral cavity // Head and neck-journal for the sciences and specialties of the head and neck, 40 (2018), 11; 2347-2352. doi: 10.1002/hed.25330